GHK-Cu: The Peptide Everyone Is Injecting (Big Mistake?)

0:00 If you've been anywhere near the skincare aisle, a biohacking podcast, or the deepest recesses of Reddit, where people discuss injecting things that used to live exclusively in their sister's moisturizer, you've heard of GHKQ, aka the copper peptide. The stuff that's been quietly sitting in your mom's $40 face cream for 20 years is now suddenly being loaded into syringes by guys who think shooting up Chinese peptides is a personality trait. And as one of those people, I'm allowed to say that. And amazingly, this could all actually make sense. GHKQ is one of those compounds that sounds almost too good to be true. It supposedly turns back the clock on your skin, regrows hair, heals wounds faster, modulates over 4,000 genes, and may even have anti-cancer properties. It's basically the Swiss Army knife of skin deep peptides. Except much like the Swiss

0:47 Army knife that I had as a kid, nobody has actually tested whether or not the corkcrew works for its intended purpose. Personally, I just use mine to stab my dumb buddies and Boy Scouts. And no, I never made Eagle Scout, clearly. But here's the thing that nobody selling you injectable GHKQ with a discount code wants you to know. The only form of this stuff that has any data so far is the cream, the topical stuff, the serum, the stuff in the bottle with the dropper that I bought at Sephora last week while lying and telling the clerk it was for my wife. The injectable version that the internet has collectively lost its mind over. Zero published human clinical trials. Not one. Not a zilch. The number of controlled human studies on subcutaneous GHKQ is the same as the number of dates that I went on in high school, which is zero. Comment below if that surprises you. But before we go any

1:34 further, I need to ask you something, and I want you to drop your answer in the comments right now. Here's the question. Have you or anyone you've known ever used GHKQ in any form? Whether it's injectable, topical, or that copper peptide serum beauty influencers swear by? And if so, what did you actually notice? Better skin, hair regrowth? Did you just wake up one morning looking like you have Benjamin Button the last 5 years? Shout out to anyone out there who still reads books. Drop your experience in the comments down below because I genuinely want to know. And even if you haven't tried it, drop a wilted rose in the comments. I seem to get a lot of those whenever my content strays into beauty Tik Tok. Your engagement literally feeds the algorithm which feeds this channel which then feeds Ronic who I'm pretty sure subsists entirely on Monster Energy and the likes of our subscribers. What's up my lab route army? I'm Dr. Alex. I'm a

2:19 board-certified urologist and fellowship trained men's health specialist. I run the men's health center at Urology of Indiana and I make videos on this channel where I take the stuff that wellness and biohacking community is obsessing over and run it through the filter of actual published medical literature with a sprinkling of questionable humor mixed in. Somebody has to do it and apparently it's me. This is my life now. And today we're talking about GHKQ, aka the copper peptide, aka copper tripeptide 1, aka that weird blue stuff in the syringe. if you make the mistake of wandering into beauty Tik Tok. So why should you care? Because GHKQ is one of the most interesting peptides in existence. It was discovered over 50 years ago. It has legitimate published science behind it. And it can genuinely modulate thousands of genes. The topical data is super

3:05 solid. And the injectable version that everyone is going crazy over right now has no human evidence whatsoever. This is a compound where the science and the hype exist in two completely different zip codes and we need to talk about that. Plus, the regulatory landscape surrounding it may be about to change significantly. RFK Jr. just went on Joe Rogan and announced that approximately 14 peptides currently on the FDA's banned list are about to come legal for compounding again, allegedly. And GHKQ's injectable form is on that list. So, this video matters right now. Whether you're someone who's been using it, someone who's curious and someone who wants to learn more, or maybe someone who's desperately wrestling with a worsening midlife crisis brought on by overly heavy upper eyelids and the fact that their 20s were sacrificed on the altar of medical training. I see you. At

3:50 least I would if I could see anything out of these things. Let's get into it. So, what is GHKQ? Let's start with the name. GHK stands for glycadyline. Those are three amino acids. Glycine, histadine, and lysine. The Cu is copper, specifically a dvalent copper ion Cu2+. The peptide grabs onto the copper and forms a stable complex. Total molecular weight is about 403 dolins. For reference, that is tiny. BPC57 is 1,419 dolton and simaglutide is over 4,000. So when you're thinking about the size of GHKQ, imagine you versus the peptide your girlfriend told you not to worry about. And here's where it gets interesting. GHKQ isn't some synthetic creation dreamed up in a lab trying to sell you something. It's actually totally natural, unlike my testosterone level.

4:36 >> What did he say? >> See, your body actually makes GHKQ. It's naturally present in your blood plasma, your saliva, and your urine. At age 20, your plasma levels sit around 200 NOGS per milliliter. But by age 60, that drops to about 80 NOGS per milliliter. That's a 60% decline. And that decline happens to coincide almost perfectly with the age related decrease in your body's ability to heal and regenerate tissue. That's not a coincidence. Maybe. And its discovery story is actually pretty fantastic. It all starts in 1973 at the University of California of San Francisco. A biochemist named Dr. Loren Pickart was testing liver tissue when he noticed something wild. When he took liver cells from older patients, people in their 60s,7s, and 80s, those cells were producing proteins at a rate typical of aged tissue. Obviously, that's how aging works. But when he

5:22 incubated those same old liver cells in blood plasma taken from young donors, something remarkable happened. The old cells started behaving like young cells. They restarted producing proteins at rates characteristic of a 20-year-old's tissue. Young blood was making old tissue act young again. Ronic, bring me my blood boy. Just so you're aware, when I was writing the script, this is the part where I had to use every bit of personal restraint possible to not just start ranting about the Illuminati, Adrenochrome, and Bohemian Grove. But anyways, Pickart isolated the factor responsible for this rejuvenating effect on albumin fraction of human plasma and it turned out to be a tiny tripeptide with just three amino acids and a very strong affinity for copper. And in 1977, Harvard chemist David Slesinger confirmed the exact sequence. Glycil

6:07 Lhistadil Llysine. Subsequent work showed that the copper complex GHKQ was the biologically active form. Pickart proposed that GHKQ functions as a copper shuttle, delivering copper into cells to activate regenerative processes. Now, Pikart didn't just discover GHKQ and move on. He basically spent his entire career on this compound. He published extensively, founded a company called Skin Biology, and championed the peptide for wound healing and anti-aging applications until his death in 2023 at age 85. So, say what you want, but the man dedicated 50 years of his life to a single molecule. That's either an inspiring story of scientific persistence or an absolutely unhinged level of autism. Respect either way. So that's where GHKQ came from. A naturally occurring peptide in your blood that makes old tissue act young. Discovered

6:54 by a guy who essentially dedicated his entire life to studying it. All right, so let's talk about how GHKQ actually works. And I will warn you, much like what happened in our Wolverine stack video, link up here somewhere, this is the section where things are going to get a little biochemistryheavy. If you want to skip through this, like I wish I could have skipped through middle school, just head over to the time code that Ronic's totally going to remember to put down here. Just make sure to hit the like and subscribe button first. GHKQ is what we call a copper ion. >> It shuttles copper into cells and tissues. And copper is essential for a staggering number of biological processes. It's required for enzymes involved in cellular respiration, antioxidant defense, blood clotting, melanin production, connective tissue formation, and more. The problem is is that free copper is actually toxic. It

7:41 generates reactive oxygen species, damages proteins, and generally cause all sorts of cellular havoc. GHKQ solves this by binding copper so tightly that it silences copper's redux activity while still delivering it to the right cellular targets. Think of it as an armored escort from one of your body's most essential but dangerous micronutrients. I think of Bane being transported in like an armored car. I was born in the darkness. Here is what's remarkable, though. The binding affinity of GHK, which is tiny for copper, is comparable to the copper transport site on human serum albumin, which is gigantic. And that's the primary copper carrier in your blood. In fact, GHK can actually pull copper directly off album. The published binding constant is log 10= 16.44 for GHKQ versus 16.2 for

8:28 albumin. So, GHKQ is slightly greedier for copper than the biggest protein in your blood. For a three amopeptide, this is a super efficient and it means this little guy is punching way above his weight class. But copper delivery is just the beginning. And here's where it gets wild. GHKQ influences the expression of over 4,000 human genes. 4,000. That's not a typo. Gene profiling studies using broad institute connectivity map showed that GHKQ upregulates genes involved in tissue regeneration, DNA repair, antioxidant defense, and the ubiquitin proteone pathway while simultaneously downregulating genes associated with inflammation, fibrosis, and cancer progression. Researchers basically describe it as essentially resetting the whole genome towards a healthier state.

9:14 Now, when I read that the first time, my reaction was basically, okay, that sounds like marketing copy from a supplement company. But this data comes from legitimate gene expression analyses, not from a website that sells copper peptide serum next to jade rollers and manifestation crystals. Comment below if you think that we should include peptide themed jade rollers in our first merch drop. Rodic says he's actually working on something, but I don't think he slept in 3 days, so he could just be hallucinating again. >> If you can't see my friend, doesn't mean he's not real. >> Now, in fiberblast cultures, GHKQ stimulates collagen synthesis at concentrations as low as one picolar. That's 10^ the -12 molar with maximum stimulation at one nanomar. For context, one nanomer is approximately 0.4 nanogs per milliliter. That is an absurdly low

10:01 effective concentration. Most drugs need microar to millimmer concentrations to do anything. GHKQ is active at doses a thousand to a million times lower. This thing just whispers and your cells listen. Much like how I would drop everything and blow up my whole life if Sydney Sweeney just whispered my name. GHKQ also increases production of sulfated glycosaminoglycans, specifically dermatan sulfate and hepin sulfate. It upregulates MMP2, tim1 and tim2. For those of you who aren't biochemistry nerds, MMPs are the enzymes that break down old collagen and tims are their regulators. GHKQ activates both the demolition crew and the safety inspectors. The result is balanced extracellular matrix remodeling. Out with the old damaged collagen and in with a new. And when this works properly, it's beautiful. And when it

10:47 doesn't work properly, we get to the copper uglies, which I promise we will get to cuz it is both terrifying and kind of hilarious. So, let's rattle off some of the heaviest hitters amongst the 4,000 plus genes that GHKQ modulates because they matter. And also, this gives me a chance to sound smart, which if you've ever had to talk to me IRL, you know this is a rare thing indeed. Starting off with the C one/stat 3 axis, GHKQ upregulates 1 and suppresses phosphorolated stat 3. Now, if you've been in the longevity space, you know about cert one. It's the longevity gene that reservatrol was supposed to activate before that whole thing totally fizzled out. And GHKQ does this at nanomolar concentrations. It also promotes mucosal healing by increasing tight junction proteins ZO1 and oludin

11:32 as a gut health mechanism. This is legitimately interesting. Next is NRF2 and NFKB modulation. In pulmonary fibrosis models, GHKQ modulates the NRF2 antioxidant pathway and suppresses NFKB inflammatory signaling. It also interferes with TGF beta 1 SMAD 23, which is one of the master drivers of fibrosis. If you've ever wondered why some people with lung scarring or chronic inflammation are interested in this peptide, this is why. And as someone who has suffered with nerd asthma throughout all of adolescence and flares even now, this piques my interest. Of course, that's autoimmune and not a fibrosis thing, but shut up. Let me let me dream. Next is copper dependent growth factors. GHKQ stimulates expression of BDNF which is brain derived neurotrophic factor. BMP2 which is important for bone formation and VEGF which drives blood vessel

12:18 growth. It does this through copper chaperones SOD1, CCS and ATOX1. And as a penis doctor who spends a lot of time thinking about blood flow, the VEF upregulation is personally interesting. Consider me intrigued. And in a mouse colitis model, GHKQ significantly reduced disease activity scores, suppressed TNF alpha, IL6 and IL1 beta, increased goblet cell numbers, and inhibited TH7 cell mediated inflammation. It also helped in the bleomy induced pulmonary fibrosis models, silicosis models, and even asthma models. There it is. And in asthma patients, plasma GHK levels were significantly lower than in healthy controls, which is suggestive of a real physiologic role in airway homeostasis. And on the neuroprotection front, GHK prevents copper and zinc induced protein aggregation and central nervous system cell death in vitro. Protein aggregation

13:05 is implicated in Alzheimer's, Parkinson's, and other neurogenerative diseases, which also includes trend use. Yep, trenalone cooks your gray matter. Deal with it. And now, before anyone starts injecting GHKQ hoping to prevent trend induced dementia, this is in cell culture data, not human data. But it is mechanistically compelling. Trend video up here somewhere. And here's a little known fun fact. In rat studies, GHK at just 0.5 micrograms per kilogram reduced aggressive behavior and anxiety-like behavior. In maze tests, this anxolytic effect was actually strongest at the lowest dose with larger doses having smaller effects. So, it has an inverted dose response curve for anxiety, which is unusual and kind of fascinating. Whether it does this in humans remains completely unknown, but I can't help notice the overlap of the demographic of people who inject peptides from China and people who could probably use

13:51 something for their anxiety. I'm just saying. All right, so here's where the story takes a turn from legitimate scientific discovery to why is this in a syringe on the internet. Welcome back to all you goobers who skip the science class. Let's trace the commercial journey of GHKQ. In the late 1980s, the wound healing world started paying serious attention to GHKQ. Researchers at the University of Ryman, France, led by Bella McCart, showed that GHKQ stimulated collagen synthesis in skin fiberblast, increased wound protein and glycosaminoglycin accumulation, and accelerated connective tissue healing in rat wound models. Collagen synthesis was stimulated at twice the rate of non-colagen proteins, and a control peptide with a different sequence had zero effect. This confirmed the specificity of GHKQ's action. And by the 1990s and 2000s, GHKQ had made the jump

14:39 from wound healing research to cosmetics. It started appearing in anti-aging creams, serums, and eye creams under the INCI name copper tripeptide 1. Controlled human studies on aged skin showed that topical GHKQ tightened skin, improved elasticity and firmness, reduced fine lines, wrinkles, photo damage, and hyperpigmentation, and it increased keratinocite proliferation. One study had women apply GHKQ facial cream daily for 3 months and it showed increased skin density and thickness with reduced sagging. And honestly, this is the part of GHKQ story that's actually solid. There are real human studies here published, peer-reviewed, showing measurable improvements in skin quality with topical application. If you're using a copper peptide serum right now and wondering if it works, the answer is absolutely. The data supports

15:24 topical GHKQ for skin rejuvenation, and that is legitimate dub. The uh hair data is also intriguing. GHKQ increases hair follicle size, promotes nerve outgrowth and angioenesis, and appears to extend the antigen growth phase of hair follicles. It's been used to improve hair transplant outcomes. No word yet on whether or not it can single-handedly overcome that last mastron cycle, though. Now, that being said, we're still lacking large-scale randomized control trials for hair growth specifically. So, pump the brakes a little bit if you're expecting to go from bald to Fabio. And now, here's where we make the jump, and it's a big one. Now, at some point, the peptide community looked at GHKQ and said, "If rubbing this on your face makes your skin better, imagine what injecting it directly into your body would do." And to be fair, this logic actually isn't insane. Topical GHKQ faces a major delivery problem. The peptide is highly

16:10 hydrophilic, meaning it loves water and hates crossing the lipid barrier of intact skin. Studies measuring permeation through human skin found essentially negligible penetration without some kind of enhancement. Whether that's micro needling, liposal carriers, or chemical penetration enhancers. Ironic, you're a chemical penetration enhancer. So when you put GHKQ serum on your face, most of it is just sitting on the surface. Some gets through enough to produce the effects we see in clinical studies, which makes sense. It needs tiny concentrations to work, but you're probably only getting a fraction of the potential biologic activity. The thinking was, let's just bypass the skin entirely, inject it subcutaneously, get full systemic bioavailability, let it circulate throughout your entire body, get the gene modulation, the collagen synthesis, the anti-inflammatory

16:56 effects, the neurop protection, all of it everywhere, all at once. Ronic, isn't that a movie? I don't know. Shout out in the comments down below if that's actually a movie. And I have to be honest with you from a pharmacological standpoint that reasoning is not stupid. It makes sense. But making sense and having evidence are two very different things. Making sense on paper is how we got to bloodletting labbotoies and AG1 videos up here. So let me be clear about the current state of the evidence. There are zero published human clinical trials evaluating injectable subcutaneous GHKQ for any indication. None. The protocols floating around online, one to two milligrams subq daily for 30 to 60 days cycles with equal time off. These are not from clinical guidelines. They are from form consensus practitioner experimentation and the same kind of

17:41 vibes based dosing that we've talked about with BPC157 and TB500. Some of these people that are designing these protocols are very smart and thoughtful. Some of them are also promoting their discount code. Discernment is your responsibility. So why has Injectable GHKQ exploded in popularity right now? Well, there are a few reasons. One, the broader peptide boom driven by simaglutide and BPC57 has made the general public much more comfortable with the idea of injecting peptides. Meanwhile, we've been injecting [ __ ] bat for how many years? Two, the skin care to biohacking pipeline is real. People who started with topical copper peptides wanted more. Three, GHKQ has a uniquely compelling mechanism story. Modulating 4,000 genes sounds way sexier than promotes collagen synthesis, even

18:27 though they're describing the same phenomenon. And four, the compound got caught up in the FDA's 2023 crackdown on compounded peptides, which paradoxically made it that much more desirable. Nothing drives demand like being told that you can't have something. Human psychology is beautiful like that. All right, so we've established that the injectable evidence is essentially zero from a clinical trial standpoint. But people are using this stuff and I want to be fair about what they're reporting. So, let me give you the anecdotal landscape first. The most commonly reported benefits are by far the skin quality improvements. User forums on Reddit, Excel Mail, and all the various peptide communities consistently report improvements in skin texture, firmness, elasticity, and overall glow. The second is wound healing acceleration. Users report that cuts, scrapes, and surgical incisions heal notably faster. This is consistent with the extensive

19:13 pre-clinical wound healing data and it's one of the more biologically plausible anecdotal claims because wound healing is where the strongest published evidence exists even if it is primarily from topical and animal studies. The third is hair improvements. This one's a little bit more mixed. Some users report noticeable improvements in hair density and thickness over 3 to 6 months. Others report nothing. One interesting anecdotal observation that keeps popping up is that several users note that the injection sites tend to develop thicker skin over time with one describing it as getting harder and harder to inject as the skin at injection sites actually thickens. Now, whether or not that is a side effect or proof that collagen stimulation is working depends on your perspective. And fourth are the general anti-aging effects. And to be honest, this is the vaguest category and it's the hardest to evaluate. People report feeling younger, having more energy, sleeping better, and recovering from

19:58 workouts faster. But these are the kinds of subjective claims that are impossible to disentangle from placebo, lifestyle changes, or the powerful psychological effect of doing something proactive about your health. And fifth is the copper uglies. And I need to talk about this because it freaks people out, but it's actually kind of fascinating from a biologic perspective. Some users, primarily with topical use, but occasionally with injectable, report that their skin actually looks worse after starting GHKQ. More wrinkled, more sagging, and accelerated aging and appearance. Now, the internet has dubbed this phenomenon the copper uglies, and it's controversial. Some dermatologists dismiss it entirely. Some skincare communities treat it as gospel. But what's the likely explanation? So, remember how I said that GHKQ upregulates both collagen synthesis and MMPs, the enzymes that break down old collagen? The theory is that in some

20:45 people, especially at higher concentrations or with aggressive dosing, the breakdown machinery runs faster than the rebuilding machinery. The demo crew has showed up, but the construction workers are still in their lunch break. The result is a net collagen loss, at least temporarily. A 2016 study published in scientific reports found that GHKQ significantly increased MMP-1 gene expression at its lowest tested concentration. MMP-1 is the enzyme that initiates collagen fragmentation. So, there is a plausible mechanism here. The good news is that most people who experience the copper uglies report that it resolves within 2 to four weeks of stopping. And some practitioners believe it's actually a sign of remodeling that's going on, but just needs more time to complete. Start low, go slow, and give your fiber blast time to catch up. They have a very certain pace. They can't be bullied into working faster, much like Ronic. God knows I've tried. But let's talk about

21:31 what can actually go wrong when you inject a copper containing tripeptide into your body on a daily basis without published human dosing guidelines. Fun conversation. Let's get into it. Okay. Okay. We'll do the good news first. GHKQ has a genuinely favorable safety profile in the data that we do have. In vitro GHKQ showed no cytotoxicity to keratinocytes at concentrations up to 580 microar which is way above anything used clinically or cosmetically. And here's the important part. It did not upregulate skin irritation biomarkers like IL1 alpha IL8 or FOS L1 even at high concentrations. Copper chloride and copper acetate by contrast were significantly cytotoxic and inflammatory at equivalent doses. This tells us that the safety of GHKQ is specifically because the copper is complex with GHK

22:16 and not free. Now in the bleomy induced pulmonary fibrosis model that I mentioned earlier, intraparitinal GHKQ doses ranging from 0.2 to 20 micrograms per gram per day showed protective effects with no observable adverse effects or organ toxicity. And in zebra fish, GHKQ actually rescued copper induced cardiotoxicity at concentrations as low as one nanomer without causing any cardiovascular side effects on its own. So, the compound actually seems to protect against copper toxicity rather than cause it, which is genuinely reassuring. Now, from user reports and practitioner accounts, the most common side effects of injectable GHKQ are mild and local. Redness at injection sites, itching, a small bump or puffiness that resolves within a few hours. Some users report a pink or red area that lasts 24 to 48 hours, which is thought to be related to the copper content causing slightly more local reaction than other

23:03 peptides, but rotating injection sites daily helps, which you can do with any peptide. Some people report mild nausea. Some people report transient dizziness or lightheadedness, but these are all generally self-limiting. But what about copper accumulation? This is the concern that comes up most often. Copper is an essential trace element, but excess copper can be toxic. It can cause liver damage, neurological symptoms, and GI distress. Your body has regulatory mechanisms for copper absorption through the GI tract. But these are completely bypassed when you inject copper directly into subcutaneous tissue. Now, the European Food Safety Authority established an acceptable daily intake for copper of 0.07 07 milligrams per kilogram per day with a total safe intake up to 5 milligs per day per adults. And at in typical injectable doses of 2 milligrams of GHKQ, you're injecting approximately 0.32 milligs of

23:48 elemental copper, which is well above the daily safety limit. That's injecting, not consuming. And again, that's assuming your dietary copper intake is normal and your copper metabolism is functioning properly. So if you have Wilson's disease, minky syndrome, or any undiagnosed copper metabolism disorder, injecting GHKQ could potentially be a problem. Shout out to anyone medical watching my channel who just had a step one exam induced PTSD episode after hearing about Wilson's disease. I have three words for you. Kaiser fleer rings. Another potential issue is copper zinc balance. Some practitioners recommend supplementing with zinc while using GHKQ because copper and zinc compete for absorption and maintaining the ratio matters. This is theoretical but it's reasonable from a nutritional standpoint. Chronic copper exposure without attention to zinc status could in theory shift the ratio unfavorably. Now what about pro-angioenic activity?

24:34 Just like we discussed with BPC57, GHKQ promotes blood vessel growth. It upregulates VEGF. Angioenesis is how tumors get their blood supply. So the cancer question here is the same one that we raised with BPC57. Does promoting angioenesis increase cancer risk? Now my personal take is that if everything that caused VegF upregulation cause cancer, then my bodybuilder buddies blasting GH will be dropping like flies from the big sea. But that just isn't reality. Now, interestingly, GHKQ actually has some anti-cancer data. Gene expression studies show that it upregulates over 80 cancer suppressing genes and downregulates several cancer promoting genes. It reactivates apoptosis and neuroblastoma and lymphoma cell lines. In one study, GHKQ combined with ascorbic acid remarkably suppressed saroma growth in mice. So the picture is

25:20 more nuanced than angioenesis equals cancer. But we just don't have long-term human data. We we just don't. Now a practical dosing problem is that we have no human pharmacocinetic data for injectable GHKQ. We don't know the elimination halfife. We don't know how it distributes systemically. We don't know if daily injections lead to tissue accumulation over weeks to months. Now, the pharmacocinetic studies that do exist show that the peptide is hydrophilic and likely distributes in extracellular fluid, binds to albumin, and is eliminated renally. It's also susceptible to hydraytic cleavage with histadine identified as a key degradation product, but likely and probably are not the same as objectively measured in humans. Not that that's ever stopped any of you guys. And then there's a sourcing problem. same issue as every other peptide we cover on this channel. Because injectable GHKQ is not FDA approved, anyone using it is either getting it from a compounding pharmacy

26:06 operating a legal gray zone or from a research chemical supplier operating in a similar legal gray zone with just slightly worse lighting and also a website that sells mixing kits. But that may change with RFK's promised policy changes, maybe. Which then brings us to the legal landscape because things are getting very interesting very quickly. GHKQ occupies a unique regulatory position that is actually different from most of the peptides we've covered on this channel. And here's the nuance. In September 2023, when the FDA went on its peptide crackdown and moved 19 compounds to category 2 on the 503A bulk drug substances list, effectively banning them from being compounded by pharmacies, GHKQ got a split decision. Topical GHKQ was placed in category 1, meaningarmacies can legally compound it into creams, serums, and topical preparations. But injectable GHKQ was

26:53 flagged for safety concerns and effectively restricted. The FDA's reasoning was concerns about the imogenicity, purity, and the absence of human safety data for injectable routes. So yes, your dermatologist can legally prescribe you a compounded copper peptide cream. But the injectable version that everyone on TikTok is injecting, well, it's legally problematic, which is why most of the supply has been coming from the gray market. And here's where things get spicy. On February 27th, 2026, HHS Secretary Robert F. Kennedy Jr. went on Rogan episode 2461 for those that are interested and announced that approximately 14 of the 19 peptides currently on the FDA's category 2 ban list will be moved back to category 1 status. He said, and I'm paraphrasing here, that the FDA is expected to take action within weeks to give people

27:39 access to these compounds from ethical suppliers. He described the prior ban as FDA overstepping its authority and argued that the ban actually created the gray market by pushing patients away from regulatedies toward unregulated sources. Now, I would argue that the FDA's concerted effort to shut down all compoundingies is also overstepping their authority, but hey, I'm just a talking head on the internet. Now, here are some important caveats that the excitement machine on social media is glossing over. The first is that as of the date I'm recording this video, no formal FDA rule has been published. No Federal Register notice has been issued. Kennedy's statements on a podcast, however influential, are not the same as regulatory action. He's the HHS secretary, not the FDA commissioner. He can influence policy direction, but he can't unilaterally rewrite federal drug law by chatting with Joe. That's just

28:25 not how this works. Second is that even if these peptides move from category 2 to category 1, that does not mean that they become FDA approved drugs. Category 1 means that pharmacies can legally compound them under section 503A. You still need a prescription. the compounds would still lack formal clinical indication approval, phase three trial data, and standardized dosing guidelines. This is an important distinction that is getting lost in the noise. Compounding eligibility is not the same as FDA approval. And the third is that five peptides have already been pulled from category 2 as part of a settlement with compounding pharmacy trade groups. In September 2024, CJC1295, Ipamorland, Thyosin Alpha 1, AODD9604, and Sank were sent to the pharmacy compounding advisory committee for review. And in every case, the FDA recommended against inclusion on the

29:11 allowed list, and so the PCAC voted against them. So even going through the process doesn't guarantee a favorable outcome. The wheels of regulatory change grind slowly and sometimes they grind backward. Fourth is that there is a lawsuit challenging the FDA's category 2 designations for several peptides with an FDA representing that a final rule is expected no later than March 2027. So even in the best case, we may be looking at months to over a year before the regulatory dust settles. So here's my optimistic take and I do think cautious optimism is warranted. If injectable GHKQ moves back to category 1, it means you'll be able to get pharmagra compounded GHKQ from a licensed inspected pharmacy with proper COAs prepared under a pharmacist guidance that is unambiguously better than the

29:57 current situation where most people are sourcing it from gray market websites. And I agree with Kennedy's broader argument, which is that the ban pushed people to less safe sources and created the very safety problem the FDA claimed to be solving, which is honestly hard to argue with. The question is whether or not those words turn into action and GHKQ is actually a relatively strong candidate for reclassification. It has a long safety record in topical use. The pre-clinical toxicology data is clean. The mechanisms are well characterized. The compound is indogenous, meaning your body already makes it. And compare this to some of the more exotic peptides on the list, and GHKQ looks like the honor student of the bunch. So yes, legal access to injectable GHKQ through compoundingies appears to be on the horizon. But don't book your celebration beauty bash just yet. Wait for the actual FDA announcement. All right,

30:43 let's go ahead and wrap this up with my honest assessment as a physician. GHKQ is a genuinely fascinating compound with a level of biological plausibility that is rare in the peptide world. A naturally occurring tripeptide that declines with age, modulates over 4,000 genes, stimulates collagen at peakar concentrations, promotes wound healing, and has anti-inflammatory and neuroprotective properties, and comes with a half century of research behind it. That is a hell of a resume. And the topical story is solid. There are real human studies showing real improvements in skin quality. If you're using a well- formulated copper peptide serum, the science supports you. That's legitimately one of the better evidence cosmetic ingredients out there. And the injectable story, well, it's compelling in theory, but completely unproven in human clinical trials. Every benefit that people report from injectable GHKQ

31:28 is extrapolated from topical human data, animal models, cell cultural experiments, and anecdotal user reports. The mechanisms make sense. The pre-clinical safety data is reassuring, but we still have zero randomized control trials, zero standardized dosing protocols, zero measured pharmacocinetics in humans for injectable administration. And that's a problem. Now, does this mean it doesn't work? Absolutely not. Absence of evidence is not evidence of absence. And the logical pharmacological case for a systemic administration having broader effects than topical application is sound. But I've been a doctor long enough to know that this should work in theory. Has a nasty habit of not always painting out in practice. Anyone here remember the amazing initial data surrounding the COVID jab? The risk profile is probably favorable. GHKQ is endogenous. The pre-clinical toxicology

32:14 is clean. The copper load at typical doses is well within safe limits. But probably favorable is doing a lot of heavy lifting here when you're talking about daily injections over weeks to months without pharmaccoinetic data. And Wilson's disease patients or anyone with hypatic dysfunction should absolutely stay away. Everyone else should at a minimum consider having their copper levels monitored and opt for a farmer grade product from a licensed pharmacy when it becomes available. But in order for that to happen, we need the regulatory landscape to change. Now, if the FDA follows through on RFK's announced reclassification, injectable GHKQ could be legally available through legit compoundingies within months. That's good news for patient safety, even if it doesn't change the underlying evidence base. Legal access to quality control product is always better than the wild west we have now. Now what I

33:00 would love to see is what I always want to see. Properly designed clinical trials. GHKQ has earned that investment. The pre-clinical data is strong enough to justify human trials for wound healing, skin aging, potentially even pulmonary fibrosis or colitis. These trials should happen. The compound deserves better than to be relegated to skincare aisles and gray market syringes. But until then, I'm going to keep doing what I do, giving you the actual science, telling you what we know, what we don't know, and where the line between evidence and hype actually falls, so you can make your own informed decision with actual data while tolerating my chronically online unique elder millennial brand of humor, because this is my channel, damn it. So, if you found this video helpful or even just entertaining, smash that like button, subscribe if you haven't already. I put out evidence-based content on

33:46 performance enhancement, biohacking, men's health, fitness, and topics that most respectable doctors wouldn't dream of touching. But lucky for you guys, I am far from respectable. You are welcome. And most importantly, drop a comment down below answering the question from the beginning. Have you ever used GHKQ? What form? What did you actually notice? I want real stories, not marketing copy from a website that sells a product. Although, if you are the marketing team for a copper peptide company and you want to leave a comment, please do. I mean, let's be honest. A comment is a comment after all. Just be honest what you are. So, if you haven't already, check out our video on BBC57 and TV500, the Wolverine Stack, which covers many of the same themes that we discussed today. The gap between pre-clinical promise and clinical proof, the gray market problem, and the patent law issues that prevent these compounds from getting properly studied. I'm Dr.

34:31 Alex. Stay curious, stay skeptical, and remember, just because something is in your girlfriend's face cream doesn't mean you should be injecting it. Or maybe you should. After all, I just present the data. You make your own decisions. Proceed accordingly.